My Cart

Human / Cynomolgus Claudin-18.2 Protein, His,Twin-Strep Tag (Nanodisc-pro)

  • Related Products: Bridging ELISA Kit BIS-A004
Customer Reviews
Cat. No. / Size
Price
Qty
CL2-H5589-20ug
$750.00
CL2-H5589-100ug
$1500.00
CL2-H5589-500ug
$4800.00
ETA of in-stock products:2 business days
Sub-Total$ 0

Product Details

  • Application

    1. Cell based assay (FACS or functional assay)
    2. Affinity testing (SPR / BLI)
    3. Screening (ELISA)
  • Synonyms

    Claudin-18.2, CLDN18, Claudin-18

  • Source

    Nanodisc-pro Human / Cynomolgus Claudin-18.2 Protein, His,Twin-Strep Tag (CL2-H5589) is expressed from Baculovirus-Insect cells. It contains AA Met 1 - Ala 200 (Accession # P56856-2). In the region Met 1 - Ala 200, the amino acid sequences of Human and Cynomolgus Claudin-18.2 are identical.

    Predicted N-terminus: Met

    Request for sequence
  • Molecular Characterization

    Claudin-18.2 Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries a polyhistidine tag at the N-terminus, and a twin-strep tag at the C-terminus. The protein has a calculated MW of 28.5 kDa.

    *The isotype control of empty/mock nanodisc (Cat. No. APO-H5143) is sold separately and not included in protein, you can follow the link for product information.

    1. Structure

      Nanodisc-pro membrane protein is wrapped by a piece of cell membrane and scaffold, the info of scaffold can be found in above red text "isotope type control...".

    2. Synthesis Process

      Nanodisc-pro membrane protein extraction is a gentle, non-disruptive process that directly isolates full-length transmembrane proteins together with their surrounding native phospholipids from cellular membranes, without breaking or disturbing the original membrane structure. This preserves the membrane protein's natural conformational landscape and native lipid environment, yielding stable nanodisc that retain cellular phospholipids, with fully preserved biological activity—making them ideal for cell-based assays such as FACS and binding assays in antibody discovery and screening (ELISA), etc.

  • Purity

    >90% as determined by SDS-PAGE.

  • Formulation

    Supplied as 0.2 μm filtered solution in 20 mM HEPES, 150 mM NaCl, pH7.5 with glycerol as protectant.

    Contact us for customized product form or formulation.

  • Shipping and Storage

    This product is supplied and shipped on dry ice.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. The product MUST be stored at -70°C or lower upon receipt;
    2. -70°C for 3 months under sterile conditions.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Performance Data

  • Bioactivity-ELISA

     Claudin-18.2 ELISA

    Immobilized Human / Cynomolgus Claudin-18.2 Protein, His,Twin-Strep Tag (Cat. No. CL2-H5589) at 2 μg/mL (100 μL/well) can bind Anti-Claudin-18.2 Antibody with a linear range of 0.1-4 ng/mL (QC tested).

    Protocol
  • Bioactivity-SPR

     Claudin-18.2 SPR

    Monoclonal Anti-Chimeric Claudin-18.2 Antibody, Human IgG1 captured on Protein A Chip can bind Human / Cynomolgus Claudin-18.2 Protein, His,Twin-Strep Tag (Cat. No. CL2-H5589) with an affinity constant of 29.3 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).

    Protocol
  • Bioactivity-BLI

     Claudin-18.2 BLI

    Loaded Human / Cynomolgus Claudin-18.2 Protein, His,Twin-Strep Tag (Cat. No. CL2-H5589) on NTA Biosensor, can bind Monoclonal Anti-Chimeric Claudin-18.2 Antibody, Human IgG1 (AM34) with an affinity constant of 2.8 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

    Protocol
  • Bioactivity-FACS

     Claudin-18.2 FACS

    2e5 of Anti-Claudin-18.2 CAR-293 cells were stained with 100 μL of 3 μg/mL of Human / Cynomolgus Claudin-18.2 Protein, His,Twin-Strep Tag (Nanodisc-pro) (Cat. No. CL2-H5589) and isotype control protein respectively, washed and then followed by PE anti-His Tag Antibody and analyzed with FACS (QC tested).

    Protocol

Customer Reviews
Writing Reviews

Background

A tight junction protein normally confined to gastric mucosa but exposed on tumor cell surfaces during malignant transformation. It is a premier target in gastric and pancreatic adenocarcinoma, with the monoclonal antibody zolbetuximab demonstrating significant survival benefit in CLDN18.2-positive advanced disease.

Recent Advances

 
Drug Development Progress
  • English Name:

    Claudin-18 splice variant 2

  • Category:

  • Approved Drugs:

    1 Details

  • Drugs in Clinical Trials:

    82 Details

  • Highest Development Stage:

    Approved

Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews
  • Background